Zhengwei Xie

MolClaw is an autonomous agent that evaluates, screens, and optimizes drug molecules using a hierarchical skill system, achieving state-of-the-art performance in complex workflows.

The paper constructs a synthetic yeast chromosome and identifies aging regulators through replicative lifespan studies and genome-scale analysis.

The paper identifies liquiritin as an antiviral compound that inhibits SARS-CoV-2 by mimicking type I interferon, showing efficacy in cell cultures and low toxicity in mice.